Flanigan W J, Anderson D S, Stout K, Koike T I
Nephron. 1978;22(1-3):117-23. doi: 10.1159/000181431.
The rate coefficients and fluxes of sodium across the outside and inside barriers of an in vitro, short-circuited frog skin preparation were determined in the presence of a uremic serum fraction to localize the site of action of an inhibitor of sodium transport. In unpaired studies, the mean depression of short-circuit current (SCC) resulting from the addition of the uremic serum fraction (21.9+/-2.2%) was significantly greater than the decrease in SCC resulting from either frog Ringer's wash or normal serum fractions. Paired studies comparing active and inactive uremic serum fractions indicated that the reduction in net sodium transport, whether calculated from changes in SCC(-0.55+/-0.12muEq/h) or changes in unidirectional Na fluxes (-0.56+/-0.15 muEq/h) was significantly greater in hemi-skins treated with the active fraction. The depression in sodium transport was associated with a significant decrease of sodium movement from the skin to the inside compartment, phi22 (-0.62+/-0.2 muEq/h). The results of these studies suggest that the inhibition of sodium transport ascribed to the uremic serum fraction is due to an inhibition of the active transport mechanism located at the serosal barrier.
在尿毒症血清组分存在的情况下,测定了体外短路蛙皮制剂中外侧和内侧屏障处钠的速率系数和通量,以确定钠转运抑制剂的作用位点。在非配对研究中,添加尿毒症血清组分导致的短路电流(SCC)平均降低(21.9±2.2%)显著大于蛙林格氏液冲洗或正常血清组分导致的SCC降低。比较活性和非活性尿毒症血清组分的配对研究表明,无论是根据SCC变化(-0.55±0.12μEq/h)还是单向钠通量变化(-0.56±0.15μEq/h)计算,活性组分处理的半皮肤中净钠转运的降低都显著更大。钠转运的降低与钠从皮肤向内侧隔室的移动显著减少有关,即φ22(-0.62±0.2μEq/h)。这些研究结果表明,归因于尿毒症血清组分的钠转运抑制是由于位于浆膜屏障处的主动转运机制受到抑制。